Unlike with AXP2258 combination with pirfenidone, the combination of AXP2258 with nintedanib only significantly decreased α-SMA protein expression compared with nintedanib treatment alone in cultures of slow IPF fibroblasts. The gene discussed is ACTA1; the disease is idiopathic pulmonary fibrosis.